Literature DB >> 7478643

Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck.

K W Rosbe1, J Prazma, P Petrusz, W Mims, S S Ball, M C Weissler.   

Abstract

This study was designed to investigate the presence of nitric oxide in human squamous cell carcinoma of the head and neck. We localized the activity of nitric oxide synthase in these tumors through immunohistochemical analysis using antibodies to L-citrulline (a byproduct of nitric oxide synthase), to inducible nitric oxide synthase, and to constitutive nitric oxide synthase. We found presence of inducible enzyme in squamous cells throughout these tumors, with the highest intensity staining occurring directly around keratin pearls. Our findings suggest that inducible nitric oxide synthase activity is present in squamous cell carcinomas of the head and neck, leading us to conclude that inducible nitric oxide synthase may play a significant role in tumor growth.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478643     DOI: 10.1177/019459989511300504

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  16 in total

1.  Genetic polymorphisms in nitric oxide synthase genes modify the relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma.

Authors:  Xuesong Han; Tongzhang Zheng; Qing Lan; Yaqun Zhang; Briseis A Kilfoy; Qin Qin; Nathaniel Rothman; Shelia H Zahm; Theodore R Holford; Brian Leaderer; Yawei Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

2.  [Immunotherapy of head and neck cancer. Current developments].

Authors:  P J Schuler; T K Hoffmann; T C Gauler; C Bergmann; S Brandau; S Lang
Journal:  HNO       Date:  2013-07       Impact factor: 1.284

3.  Differential expression of apoptosis related proteins and nitric oxide synthases in Epstein Barr associated gastric carcinomas.

Authors:  Maria D Begnami; Andre L Montagnini; Andre L Vettore; Sueli Nonogaki; Mariana Brait; Alex Y Simoes-Sato; Andrea Q A Seixas; Fernando A Soares
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

4.  Part I. Molecular and cellular characterization of high nitric oxide-adapted human breast adenocarcinoma cell lines.

Authors:  B J Vesper; A Onul; G K Haines; G Tarjan; J Xue; K M Elseth; B Aydogan; M B Altman; J C Roeske; W A Paradise; H De Vitto; J A Radosevich
Journal:  Tumour Biol       Date:  2012-12-14

5.  Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.

Authors:  G M K Tse; F C Wong; A K H Tsang; C S Lee; P C W Lui; A W I Lo; B K B Law; R A Scolyer; R Z Karim; T C Putti
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

Review 6.  [Squamous cell carcinoma of the head and neck. Principles and current concepts of immunotherapy].

Authors:  T K Hoffmann; T L Whiteside; H Bier
Journal:  HNO       Date:  2005-03       Impact factor: 1.284

7.  Local lymphocytes and nitric oxide synthase in the uterine cervical stroma of patients with grade III cervical intraepithelial neoplasia.

Authors:  Cléber Sergioda da Silva; Marcia Antoniazi Michelin; Renata Margarida Etchebehere; Sheila Jorge Adad; Eddie Fernando Candido Murta
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

Review 8.  Nitric oxide and cancer: a review.

Authors:  Sheetal Korde Choudhari; Minal Chaudhary; Sachin Bagde; Amol R Gadbail; Vaishali Joshi
Journal:  World J Surg Oncol       Date:  2013-05-30       Impact factor: 2.754

9.  Differential activity of NO synthase inhibitors as chemopreventive agents in a primary rat tracheal epithelial cell transformation system.

Authors:  Sheela Sharma; Betty P Wilkinson; Pu Gao; Vernon E Steele
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

Review 10.  The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.

Authors:  Monika E Freiser; Paolo Serafini; Donald T Weed
Journal:  Immunol Res       Date:  2013-12       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.